Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 15Papillomavirus Infections 9Uterine Cervical Neoplasms 7Pancreatic Neoplasms 6Ovarian Neoplasms 5Breast Neoplasms 5Prostatic Neoplasms 4Neuroendocrine Tumors 3Neoplasm Metastasis 3Myasthenia Gravis 3Multiple Myeloma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Autoimmune Diseases 3Thyroid Diseases 2Pancreatic Cyst 2Neuroblastoma 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Hairy Cell 2Leukemia 2Hematologic Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Brain Neoplasms 2Abortion, Spontaneous 2

Interventions

Rivaroxaban 5apixaban 4Heparin, Low-Molecular-Weight 2Dabigatran 2ribociclib 1palbociclib 1edoxaban 1calcium heparin 1abemaciclib 1Tinzaparin 1Surveys and Questionnaires 1Observation 1Nadroparin 1Mass Screening 1Heparin 1Fondaparinux 1Enoxaparin 1Data Collection 1Dalteparin 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Venous Thromboembolism × Data Collection × Clear all
NCT04846556 2023-10-11

Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO

Centre Hospitalier Universitaire de Saint Etienne

Completed
300 enrolled
Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡